Decoy Therapeutics Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
DCOY$1.11+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Stockholders' Equity (Deficit)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
| Common Stock · Preferred Stock · AdditionalPaid-In · Accumulated · TotalStockholders' | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Equity | |||||||||||||||
| Balance at December 31, 2023 | 2,735 | — | — | — | 81,635,123 | (76,347,841) | 5,287,282 | ||||||||
| Issuance of equity securities, net | 5,271 | 1 | — | — | 1,526,459 | — | 1,526,460 | ||||||||
| Equity-based compensation expense | 273,730 | — | 273,730 | ||||||||||||
| Net loss | — | — | — | — | — | (5,575,777) | (5,575,777) | ||||||||
| Balance at December 31, 2024 | 8,006 | 1 | — | — | 83,435,312 | (81,923,618) | 1,511,695 | ||||||||
| Issuance of equity securities, net | 523,962 | 52 | — | 12,374,644 | — | 12,374,696 | |||||||||
| Equity-based compensation expense | — | — | — | — | 219,058 | — | 219,058 | ||||||||
| Preferred stock issued for asset acquisition | 1,674 | — | 4,302,000 | 4,302,000 | |||||||||||
| Net loss | — | — | — | — | — | (12,518,480) | (12,518,480) | ||||||||
| Balance at December 31, 2025 | 531,968 | 53 | 1,674 | — | 100,331,014 | (94,442,098) | 5,888,969 | ||||||||
Historical common stock and additional paid-in capital amounts have been recast to reflect the 1-for-8, 1-for-15 and 1-for-12 reverse stock splits effected on June 14, 2024, August 15, 2025 and March 6, 2026, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.